Letter by Xiang and Cui Regarding Article, "Low-Dose Rivaroxaban and Risks of Adverse Events in Patients With Atrial Fibrillation"-MedSci.cn

Letter by Xiang and Cui Regarding Article, "Low-Dose Rivaroxaban and Risks of Adverse Events in Patients With Atrial Fibrillation"

Xiang, Q; Cui, YM

Xiang, Q (corresponding author), Peking Univ, Hosp 1, Dept Pharm, Beijing, Peoples R China.

STROKE, 2020; 51 (1): E9